BSE · 542934
Chandra Bhagat Pharma Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹92 Cr with net profit ₹1 Cr — a 0.93% net margin, versus 0.66% the period before.
Shareholding
As of 2026-03-31
- Promoter73.02%
- Public26.98%
280 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.99× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #1 of 666 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,93,459 Cr | 24.35 | 4.83 | 3.42% | 9.3% |
| Avenue Supermarts Limited | ₹2,50,959 Cr | 381.38 | 10.26 | 12.14% | 4.32% |
| Trent Ltd. | ₹1,60,247 Cr | 92.84 | 22.94 | 24.62% | 8.57% |
| FSN E-Commerce Ventures Ltd. | ₹93,790 Cr | 1212.96 | 65.21 | 13.87% | 1.99% |
| Vishal Mega Mart Limited | ₹50,703 Cr | 56.97 | 6.83 | 11.32% | 6.61% |
| Premier Energies Limited | ₹47,038 Cr | 102.19 | 10.9 | 35.05% | 19.3% |
| Aegis Logistics Limited | ₹45,019 Cr | 109.72 | 7.44 | 14.83% | 10.78% |
| Aditya Infotech Limited | ₹40,364 Cr | 238.34 | 21.5 | 19.61% | 8.72% |
| Redington Limited | ₹22,472 Cr | 57.38 | 2.21 | 14.67% | 1.25% |
| Honasa Consumer Limited | ₹14,620 Cr | 210.96 | 10.36 | 14.16% | 8.36% |
| Chandra Bhagat Pharma Limited(this company) | — | — | — | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashChandra Bhagat Pharma Limited's shares last traded at a 52-week high of Rs 59 and a low of Rs 29.7. The company has a market capitalization of Rs 52 Cr and a debt-to-equity ratio of 0.63.
Positives
- +Promoter holding increased from 68.6947% in Sep 2023 to 73.0154% in Mar 2026.
- +The company's net profit increased to Rs 1.53 Cr in Mar 2024 from Rs 0.85 Cr in Mar 2025.
- +Debt-to-equity ratio is 0.63.
Negatives
- −Annual revenue decreased from Rs 232.70 Cr in Mar 2024 to Rs 92.20 Cr in Mar 2025.
- −Earnings per share (EPS) decreased from Rs 2.03 in Mar 2024 to Rs 1.14 in Mar 2025.
- −EBITDA decreased from Rs 3.64 Cr in Mar 2024 to Rs 3.11 Cr in Mar 2025.
Financial Performance
The company's revenue increased to Rs 232.70 Cr in Mar 2024 from Rs 92.20 Cr in Mar 2025. Net profit also rose from Rs 0.85 Cr in Mar 2025 to Rs 1.53 Cr in Mar 2024. Earnings per share (EPS) was Rs 1.14 in Mar 2025 and Rs 2.03 in Mar 2024.
Balance Sheet
Chandra Bhagat Pharma Limited has a debt-to-equity ratio of 0.63. The book value per share is Rs 38.45. No information on current assets or liabilities is available.
Ownership & Pledges
Public shareholding stands at 26.9846%. There are no pledged shares by promoters.
Shareholding Changes
Promoter holding increased from 68.2441% in Mar 2023 to 73.0154% in Mar 2026. Public shareholding decreased from 30.9077% in Mar 2023 to 26.9846% in Mar 2026. Institutional holding was 0% as of Mar 2026.
Data as of — price: 2026-07-29 · financials: Mar 25 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Chandra Bhagat Pharma Limitedshare price & fundamentals